Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Staphylokinase vs. alteplase for thrombolysis in rabbit stroke model

Oct. 16, 1997

Hirudin more effective than heparin in heart attack patients

Oct. 15, 1997

New antithrombotics/anticoagulants synthesized at Zeneca

Oct. 14, 1997

KBT-3022: pharmacokinetics and pharmacological effects in guinea pigs

Oct. 13, 1997

Merck's new fibrinogen receptor antagonists

Oct. 9, 1997

Mitsui Toatsu's antiplatelet agent slated to enter clinical testing

Oct. 6, 1997

Neutralase proceeds to phase III trials

Oct. 3, 1997

Cor Therapeutics submits NDA amendment for Integrilin to FDA

Oct. 2, 1997

Clinical results presented for Knoll's PEG-hirudin

Sep. 30, 1997

SKB reports new antiplatelet agents

Sep. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...